Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 7,017,955B 4,088B 3,771B 3,483B 6,608B 445,748B 6,719B 45,054B 17,693B 219,590B 17,548B 17,166B 754,903B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 7,263,125B 4,231B 3,902B 3,604B 6,839B 461,320B 6,954B 46,628B 18,311B 227,261B 18,161B 17,766B 781,275B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.4%
Yield 2019 *
-
Yield 2020 -
1 day+1.74%
1 week-2.15%
Current month+0.24%
1 month-1.56%
3 months-26.79%
6 months-35.74%
Current year-29.31%
1 week 39,900
Extreme 39900
43,100
1 month 38,950
Extreme 38950
45,450
Current year 38,950
Extreme 38950
78,300
1 year 38,950
Extreme 38950
78,300
3 years 38,950
Extreme 38950
124,463.12
5 years 38,950
Extreme 38950
146,932.97
10 years 13,660.97
Extreme 13660.9749
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 52 -
Director TitleAgeSince
Chairman 68 28/03/2025
Director/Board Member 77 28/03/2023
Director/Board Member 65 26/03/2021
Date Insider Type Main position Quantity % Market Cap.
07/05/25Others 127 0.0003%
07/05/25Fiscal year 4,500 0.0103%
07/05/25Others 24 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%-2.15%-22.27%-33.08% 1.21B
-0.17%+1.61%+16.42%+85.22% 48.69B
+1.04%-1.02%+69.47%+115.88% 36.38B
-0.13%-1.29%-2.60%+41.58% 12.19B
-0.71%+0.89%+18.28%+97.87% 12.04B
-0.76%+0.38%+33.16%+123.08% 9.04B
-0.86%+0.37%+52.61%-3.54% 7.06B
+0.75%-0.82%+17.49%+44.79% 7.09B
+0.69%+3.25%+19.90%+243.91% 6.75B
+5.45%-7.36%-17.93%+13.17% 6.1B
Average +0.70%-0.46%+18.45%+72.89% 14.66B
Weighted average by Cap. +0.35%+0.09%+29.40%+89.68%

Financials

2019 2020
Net sales 174B 260,545B 152B 140B 129B 245B 16,549B 249B 1,673B 657B 8,152B 651B 637B 28,026B 234B 350,724B 204B 188B 174B 330B 22,276B 336B 2,252B 884B 10,974B 877B 858B 37,726B
Net income 8.6B 12,917B 7.52B 6.94B 6.41B 12.16B 820B 12.37B 82.92B 32.56B 404B 32.3B 31.6B 1,389B 20.94B 31,443B 18.32B 16.89B 15.6B 29.61B 1,997B 30.1B 202B 79.27B 984B 78.62B 76.91B 3,382B
Net Debt 149B 223,066B 130B 120B 111B 210B 14,168B 214B 1,432B 562B 6,980B 558B 546B 23,995B 163B 245,171B 143B 132B 122B 231B 15,572B 235B 1,574B 618B 7,671B 613B 600B 26,372B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
10/07/26 ₩41,000.00 +1.74% 78,861
09/07/26 ₩40,300.00 -1.23% 87,107
08/07/26 ₩40,800.00 -2.16% 78,322
07/07/26 ₩41,700.00 +0.85% 88,530
06/07/26 ₩41,350.00 -1.31% 48,604
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock